Minimum Investment
₹139,000
Price Range
₹132 to ₹139
Lot Size
1000 shares
Issue Size
₹52 Cr
About the Company
Incorporated in August 2015, Bio Medica Laboratories specialises in manufacturing pharmaceutical parenteral formulations, producing a wide range of ethical drugs, generic drugs, and over-the-counter (OTC) medications in liquid and dry-powder injectable forms.der injectables. These injectables are available in both single-dose and multi-dose formats, serving the needs of both human and veterinary healthcare.
Bookbuilding IPO
IPO Objectives
- Repayment of loan
- Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises
- General Corporate Purposes
Important Dates
| Bid/Offer Opens On | 21-05-2026 |
| Bid/Offer Closes On | 25-05-2026 |
| Finalisation of Basis of Allotment | 26-05-2026 |
| Initiation of Refunds | 27-05-2026 |
| Credit of Shares to Demat | 27-05-2026 |
| IPO Listing Date | 29-05-2026 |
IPO Subscription Status
| Category | Offered Shares | Applied Shares | Times |
|---|---|---|---|
| QIB | 36,000 | 574,000 | 15.94x |
| NII | 1,755,000 | 2,475,000 | 1.41x |
| NII ( >10 lakh) | 1,170,000 | 1,193,000 | 1.02x |
| NII ( <10 lakh) | 585,000 | 1,282,000 | 2.19x |
| Retail | 1,792,000 | 0 | 0.00x |
| Total | 3,583,000 | 3,049,000 | 0.85x |
Grey Market Premium (GMP)
₹2.00
per share
Registrar
Skyline Financial Services Pvt.Ltd.
Lead Managers
- Narnolia Financial Services Ltd.
Company Promoters
- Mr. Mukesh Mehta and Mr. Pradeep Mehta are the company promoters.\r\n
